Clinical research in oncology: in memory of Professor Gordon McVie

por Tannock, Ian F
Publicado 2022

The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors

por Patel, Krupa J, Tannock, Ian F
Publicado 2009

The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors

por Lee, Carol M, Tannock, Ian F
Publicado 2010

Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib

por Grantab, Rama H, Tannock, Ian F
Publicado 2012

The dosing of ibrutinib and related Bruton’s tyrosine kinase inhibitors: eliminating the use of brute force

por Ratain, Mark J., Tannock, Ian F., Lichter, Allen S.
Publicado 2022

The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts

por Fung, Andrea S, Lee, Carol, Yu, Man, Tannock, Ian F
Publicado 2015

Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors

por Yu, Man, Lee, Carol, Wang, Marina, Tannock, Ian F
Publicado 2015

The Tumor Microenvironment and Strategies to Improve Drug Distribution

por Saggar, Jasdeep K., Yu, Man, Tan, Qian, Tannock, Ian F.
Publicado 2013

Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors()()

por Tan, Qian, Wang, Marina, Yu, Man, Zhang, Junyan, Bristow, Robert G, Hill, Richard P, Tannock, Ian F
Publicado 2016

Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer

por Vardy, Janette L, Dhillon, Haryana Mary, Pond, Gregory R, Renton, Corrinne, Clarke, Stephen J, Tannock, Ian F
Publicado 2018

Duration of suppression of bone turnover following treatment with zoledronic acid in men with metastatic castration-resistant prostate cancer

por Niraula, Saroj, Templeton, Arnoud J, Vera-Badillo, Francisco, Dodd, Anna, Nugent, Zoann, Joshua, Anthony M, Tannock, Ian F
Publicado 2017

Lack of cognitive impairment in long-term survivors of colorectal cancer

por Vardy, Janette L., Pond, Gregory R., Cysique, Lucette A., Gates, Thomas M., Lagopoulos, Jim, Renton, Corrinne, Waite, Louise M., Tannock, Ian F., Dhillon, Haryana M.
Publicado 2022

Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets

por Patel, Amol, Tannock, Ian F., Srivastava, Priyanka, Biswas, Bivas, Gupta, Vineet Govinda, Batra, Atul, Bhethanabhotla, Sainath, Pramanik, Raja, Mahindru, Shubh, Tilak, TVSVGK, Das, Chandan Krishna, Mehta, Prashant
Publicado 2020

Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy

por Boström, Peter J., Mirtti, Tuomas, van Rhijn, Bas, Fleshner, Neil E., Finelli, Antonio, Laato, Matti, Jewett, Michael A., Moore, Malcom J., Sridhar, Srikala, Nurmi, Martti, Tannock, Ian F., Zlotta, Alexandre R.
Publicado 2016

Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel

por Halabi, Susan, Dutta, Sandipan, Tangen, Catherine M, Rosenthal, Mark, Petrylak, Daniel P, Thompson, Ian M, Chi, Kim N, De Bono, Johann S, Araujo, John C, Logothetis, Christopher, Eisenberger, Mario A, Quinn, David I, Fizazi, Karim, Morris, Michael J, Higano, Celestia S, Tannock, Ian F, Small, Eric J, Kelly, William Kevin
Publicado 2020